Fig. 2 | Scientific Reports

Fig. 2

From: MYH9 promotes malignant progression of glioma cells through regulating β-catenin stability via epithelial-mesenchymal transition signaling pathway

Fig. 2

MYH9 was highly expressed in human gliomas. (A) MYH9 mRNA expression in glioma tissues and para-tumor tissues among the glioma patients obtained from the TCGA database. (B) MYH9 mRNA level in gliomas from the CGGA database. (C) MYH9 had higher expression in IDH-wildtype gliomas. (D) The expression of MYH9 in tumor and adjacent samples were monitored by immunohistochemistry. (E,F) MYH9 mRNA and protein levels in glioma cell lines. (G–I) β-catenin and N-cadherin expression was positively correlated with MYH9 expression, whereas E-cadherin expression was negatively correlated with MYH9 expression from the GEPIA database. *P < 0.05, **P < 0.01, ***P < 0.001.

Back to article page